KRAS and cancer: Cancer cells protect themselves from increased levels of ROS in part by upregulating antioxidant transcription factors such as nuclear factor erythroid 2-related factor 2 (NRF2) via oncogene expression (K-Ras, B-Raf, c-Myc) [132].